Evidence map›Paper›PMID 41051588›Full record

SynthesisAIDS and behavior2026

Antiretroviral Therapy Adherence Interventions in the Era of Universal Test and Treat: A Hybrid Systematic-Narrative Literature Review of Global Evidence.

Claire M Keene, Lauren Jennings, Carl-Oscar Källström-Ståhlgren, Ingrid T Katz, Lora L Sabin, Chantel Schreuder, Yashna Singh, Catherine Orrell, Rivet Amico

Abstract readSystematic Review
In one paragraph

Synthesis in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claire M KeeneNuffield Department of Medicine, Centre for Global Health Research, University of Oxford, Oxford, UK. claire.keene@ndm.ox.ac.uk.ORCID http://orcid.org/0000-0002-0875-5884
Lauren JenningsDesmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine & Department of Medicine, University of Cape Town, Cape Town, South Africa.
Carl-Oscar Källström-StåhlgrenDepartment of Public Health, Global Health Section, University of Copenhagen, Copenhagen, Denmark.
Ingrid T KatzBrigham and Women's Hospital, Harvard Medical School, Boston, USA.
Lora L SabinDepartment of Global Health, School of Public Health, Boston University, Boston, USA.
Chantel SchreuderDesmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine & Department of Medicine, University of Cape Town, Cape Town, South Africa.
Yashna SinghDesmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine & Department of Medicine, University of Cape Town, Cape Town, South Africa.
Catherine Orrell *Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine & Department of Medicine, University of Cape Town, Cape Town, South Africa.
Rivet Amico *Department of Health Behavior Health Education, School of Public Health, University of Michigan, Ann Arbor, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An undetectable viral load (VL) in people living with HIV (PWH) is key to both individual and public health success. But for the millions of PWH on oral antiretroviral therapy (ART) worldwide, this requires consistent, sustained adherence. Review of interventions to support adherence published in recent literature can provide insights into promising and effective strategies. We conducted a hybrid systematic-narrative literature review to explore optimal adherence strategies in the era of universal test-and-treat. We searched PubMed, Scopus, and Web of Science according to PRISMA guidelines for peer-reviewed studies, available in English, including people ≥ 12 years old taking ART, published between 01 January 2015 and 18 January 2024. We extracted data on the included studies and the adherence interventions (strategies used -allocated to one of 14 a priori categories or 'other', measures of adherence, and intervention outcomes). Descriptive statistics were used for study information and those interventions with a positive effect were described narratively. We extracted data from 230 studies evaluating a total of 262 interventions among 97,037 PWH. Most studies enrolled participants in Africa (106, 46%) or North America (80, 35%). The majority randomized participants (215, 94%), including 30 cluster-randomized trials. Most included general HIV clinic populations, with 51 (22%) focused on youth and 23 (10%) on pregnant and post-partum women. Many (146, 64%) used VL as an outcome. Self-reported adherence was also a commonly used outcome (129, 56%), but a minority used self-reported measures alone (36, 16%). The most common intervention strategies included across the 262 interventions were eHealth/ mHealth technologies (90, 34%) and adherence-focused counseling (81, 31%). The majority of interventions had 'other' intervention features (133, 51%), typically combined with one or more of the a priori-defined strategies (107, 80%). Most studies evaluated an approach with multiple strategies packaged into a single intervention (k = 182/262, 70%).The majority of interventions had some evidence of effect on an adherence outcome (k = 159, 61%). In studies reporting VL outcomes, 52% (k = 87/166) found some evidence of effect, while 28% (k = 47/166) found significant effects. Intervention strategies demonstrating significant impact on VL included task-shifting and changing dispensing schedules (3/5, 60% in both), while nearly half the evaluations of economic strategies demonstrated significant impact on VL (10/21). A number of different adherence intervention strategies have the potential to impact viral suppression in different populations. Variability in intervention strategies and the resulting outcomes, supports calls to target interventions to PWH who are most likely to benefit, while at the same time addressing social determinants of health and reducing barriers to accessing care to make services more person-centered. Greater attention to evaluating flexible, tailored, complex interventions may offer valuable insights for moving towards the next generation of highly generalizable, sustainable adherence support.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsHIV InfectionsMedication AdherenceAdherence InterventionsFemaleGlobal HealthHumansViral LoadAnti-HIV AgentsAnti-Retroviral AgentsAdherenceAntiretroviral therapyHIVInterventionLiterature reviewUniversal test-and-treatViral suppression

Identifiers

PMID41051588
PMCPMC12816096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.